MedPath

Persistent Pain After Reconstruction Following Mastectomy

Completed
Conditions
Breast Cancer
Chronic Pain
Interventions
Procedure: Reconstruction
Registration Number
NCT01738048
Lead Sponsor
Rigshospitalet, Denmark
Brief Summary

A cross sectional study to determine the prevalence of persistent pain after reconstructive surgery after mastectomy for breast cancer, with a comparative analysis of a cohort treated with mastectomy without reconstruction.

Detailed Description

The aim of the study is to determine if reconstruction of the breast after mastectomy increases the risk of reporting persistent pain 2-3 years after surgery.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
1352
Inclusion Criteria
  • Patients with unilateral primary breast cancer aged 18-70 years
Exclusion Criteria
  • recurrent cancer
  • other malignancy
  • emigration
  • non-standardized treatment

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
ReconstructionReconstructionPatients treated with mastectomy followed by reconstruction
Primary Outcome Measures
NameTimeMethod
The risk of developing persistent if reconstructedCross-sectional, 2-3 years after surgery for breast cancer

The risk of developing persistent if reconstructed compared to patients mastectomized without reconstruction expressed as an odds ratio.

Secondary Outcome Measures
NameTimeMethod
Prevalence of persistent pain after reconstruction after mastectomyCross-sectional, 2-3 years after surgery for breast cancer

Self reported pain expressed as a percentage of the population of patients reconstructed with expander and autologous tissue. Pain intensity measured with a numerical rating scale 0-10, divided in mild (NRS 1-3), moderate (4-6) and severe pain (7-10). Patients regarded as having clinically relevant pain: NRS 4 or above, at least at a weekly basis.

Prevalence of sensory disturbances after reconstruction after mastectomyCross-sectional, 2-3 years after surgery for breast cancer

Trial Locations

Locations (1)

Rigshospitalet

🇩🇰

Copenhagen, Denmark

© Copyright 2025. All Rights Reserved by MedPath